# GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)

> **NCT00766493** · PHASE3 · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 250 (actual)

## Conditions studied

- Carotid Artery Stenosis

## Interventions

- **DEVICE:** GORE® Embolic Filter

## Key facts

- **NCT ID:** NCT00766493
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766493, "GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00766493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*